INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 80 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 15,232,268 | $29,094,000 | 2.84% |
| EcoR1 Capital, LLC | 412,000 | $787,000 | 0.08% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,130,432 | $2,159,000 | 0.05% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 164,605 | $314,000 | 0.04% |
| Clear Harbor Asset Management, LLC | 95,630 | $183,000 | 0.03% |
| ALGERT GLOBAL LLC | 72,556 | $139,000 | 0.03% |
| 180 WEALTH ADVISORS, LLC | 30,000 | $57,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 289,854 | $554,000 | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 85,412 | $163,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 459,000 | $877,000 | 0.01% |